Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

LRRCC1 Activators

LRRCC1, or Leucine-Rich Repeat and Coiled-Coil Domain Containing 1, is a protein encoded by the gene LRRCC1 in humans. While the complete functional spectrum of LRRCC1 is not fully elucidated, proteins containing leucine-rich repeat (LRR) domains are typically involved in protein-protein interactions and have been implicated in a variety of cellular functions, including signal transduction, cell adhesion, DNA repair, and the regulation of gene expression.

The LRR domain is characterized by a series of tandem repeats, usually 20–29 amino acid residues in length, that form a horseshoe-shaped structure with a parallel β-sheet on the concave side and helical elements on the convex side. This conformation facilitates interactions with a diverse array of protein partners. The coiled-coil domain, on the other hand, is known to mediate protein dimerization and oligomerization, suggesting that LRRCC1 may participate in forming protein complexes.Given the structure of LRRCC1, it is plausible that this protein could function as a scaffold, bringing together multiple proteins to form signaling complexes. Such complexes could be vital for the transduction of signals from the cell surface to the interior, influencing cellular responses to environmental cues. Furthermore, the coiled-coil domain of LRRCC1 might be involved in maintaining the structural integrity of these complexes or mediating interactions with cytoskeletal elements, thus potentially influencing cell shape and motility.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels, which may indirectly influence pathways associated with LRRCC1.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Activates protein kinase C (PKC), potentially affecting signaling pathways related to LRRCC1.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor, potentially affecting downstream pathways that could intersect with LRRCC1 functions.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK, which could indirectly influence LRRCC1 through the MAPK/ERK pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, potentially affecting signaling pathways related to LRRCC1.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor, potentially impacting pathways associated with LRRCC1.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, which may indirectly affect LRRCC1 activity by modulating cellular growth and metabolism pathways.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor, potentially influencing LRRCC1 activity through cytoskeletal regulation.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

Inhibits Rac1, a GTPase involved in actin cytoskeleton organization, potentially affecting LRRCC1-associated pathways.